{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:25:03Z","timestamp":1773897903551,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005296","name":"Universit\u00e4tsklinikum Regensburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005296","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Treatment of patients with laryngeal squamous cell carcinoma with radiotherapy or chemoradiation is an established alternative to laryngeal surgery in many cases, but particularly for advanced tumors without cartilage invasion. Imaging modalities face the challenge of distinguishing between posttherapeutic changes and residual disease in the complex anatomic subsite of the larynx. Guidelines concerning restaging of head and neck squamous cell carcinomas (HNSCC) are presented by the National Comprehensive Cancer Network (NCCN) and other national guidelines, but clearly defined recommendations for routine restaging particularly for laryngeal cancer are lacking.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A\u00a0systematic search was carried out in PubMed to identify studies evaluating routine restaging methods after primary non-surgical treatment of laryngeal squamous cell carcinoma from 2009 to 2020.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Only three studies were deemed eligible, as they included at least \u226550% patients with laryngeal squamous cell carcinoma and evaluated imaging modalities to detect residual cancer. The small number of studies in our review suggest restaging with fluoro-deoxy-glucose positron-emission tomography\/computed tomography (FDG PET\/CT) 3\u00a0months after initial treatment, followed by direct laryngoscopy with biopsy of the lesions identified by FDG PET\/CT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Studies evaluating restaging methods after organ-preserving non-surgical treatment of laryngeal carcinoma are limited. As radiotherapy (RT), chemoradiotherapy (CRT), systemic therapy followed by RT and radioimmunotherapy are established alternatives to surgical treatment, particularly in advanced laryngeal cancers, further studies are needed to assess and compare different imaging modalities (e.g. PET\/CT, MRI, CT, ultrasound) and clinical diagnostic tools (e.g., video laryngoscopy, direct laryngoscopy) to offer patients safe and efficient restaging strategies. PET or PET\/CT 3\u00a0months after initial treatment followed by direct laryngoscopy with biopsy of the identified lesions has the potential to reduce the number of unnecessary laryngoscopies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00066-020-01706-9","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T14:06:13Z","timestamp":1605881173000},"page":"167-176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Routine restaging after primary non-surgical treatment of laryngeal squamous cell carcinoma\u2014a\u00a0review"],"prefix":"10.1007","volume":"197","author":[{"given":"Caroline Theresa","family":"Seebauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berit","family":"Hackenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jirka","family":"Grosse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine","family":"Rennert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst-Michael","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Ugele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Michaelides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisham","family":"Mehanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias G.","family":"Hautmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Bohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9785-1386","authenticated-orcid":false,"given":"Julian","family":"K\u00fcnzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,20]]},"reference":[{"key":"1706_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel\u00a0RL, Miller\u00a0KD, Jemal\u00a0A (2019) Cancer statistics. CA Cancer J Clin 69:7\u201334","journal-title":"CA Cancer J Clin"},{"key":"1706_CR2","first-page":"CD002027","volume":"2","author":"P Dey","year":"2002","unstructured":"Dey\u00a0P, Arnold\u00a0D, Wight\u00a0R, MacKenzie\u00a0K, Kelly\u00a0C, Wilson\u00a0J (2002) Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer. Cochrane Database Syst Rev 2:CD2027","journal-title":"Cochrane Database Syst Rev"},{"key":"1706_CR3","first-page":"CD002027","volume":"12","author":"L Warner","year":"2014","unstructured":"Warner\u00a0L, Chudasama\u00a0J, Kelly\u00a0CG, Loughran\u00a0S, McKenzie\u00a0K, Wight\u00a0R, Dey\u00a0P (2014) Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer. Cochrane Database Syst Rev 12:CD2027","journal-title":"Cochrane Database Syst Rev"},{"key":"1706_CR4","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa031317","volume":"349","author":"AA Forastiere","year":"2003","unstructured":"Forastiere\u00a0AA, Goepfert\u00a0H, Maor\u00a0M, Pajak\u00a0TF, Weber\u00a0R, Morrison\u00a0W, Glisson\u00a0B, Trotti\u00a0A, Ridge\u00a0JA, Chao\u00a0C et\u00a0al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N\u00a0Engl J Med 349:2091\u20132098","journal-title":"N Engl J Med"},{"key":"1706_CR5","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1200\/JCO.2017.75.7385","volume":"36","author":"AA Forastiere","year":"2018","unstructured":"Forastiere\u00a0AA, Ismaila\u00a0N, Lewin\u00a0JS, Nathan\u00a0CA, Adelstein\u00a0DJ, Eisbruch\u00a0A, Fass\u00a0G, Fisher\u00a0SG, Laurie\u00a0SA, Le\u00a0Q\u2011T et al (2018) Use of larynx-preservation strategies in the treatment of laryngeal cancer: American society of clinical oncology clinical practice guideline update. J\u00a0Clin Oncol 36:1143\u20131169","journal-title":"J Clin Oncol"},{"key":"1706_CR6","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1200\/JCO.2012.43.6097","volume":"31","author":"AA Forastiere","year":"2013","unstructured":"Forastiere\u00a0AA, Zhang\u00a0Q, Weber\u00a0RS, Maor\u00a0MH, Goepfert\u00a0H, Pajak\u00a0TF, Morrison\u00a0W, Glisson\u00a0B, Trotti\u00a0A, Ridge\u00a0JA et al (2013) Long-term results of RTOG 91-11: a\u00a0comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J\u00a0Clin Oncol 31:845\u2013852","journal-title":"J Clin Oncol"},{"key":"1706_CR7","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1093\/annonc\/mdy332","volume":"29","author":"A Dietz","year":"2018","unstructured":"Dietz\u00a0A, Wichmann\u00a0G, Kuhnt\u00a0T, Pfreundner\u00a0L, Hagen\u00a0R, Scheich\u00a0M, K\u00f6lbl\u00a0O, Hautmann\u00a0MG, Strutz\u00a0J, Schreiber\u00a0F et al (2018) Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal\/hypopharyngeal cancer resectable only by total laryngectomy\u2014final results of the larynx organ preservation trial DeLOS-II. Ann Oncol 29:2105\u20132114","journal-title":"Ann Oncol"},{"key":"1706_CR8","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00066-019-01511-z","volume":"195","author":"J Haussmann","year":"2019","unstructured":"Haussmann\u00a0J, Tamaskovics\u00a0B, B\u00f6lke\u00a0E, Djiepmo-Njanang\u00a0F\u2011J, Kammers\u00a0K, Corradini\u00a0S, Hautmann\u00a0M, Ghadjar\u00a0P, Maas\u00a0K, Schuler\u00a0PJ et al (2019) Addition of chemotherapy to hyperfractionated radiotherapy in advanced head and neck cancer\u2014a meta-analysis. Strahlenther Onkol 195:1041\u20131049","journal-title":"Strahlenther Onkol"},{"key":"1706_CR9","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s00066-013-0414-2","volume":"189","author":"F Hoebers","year":"2013","unstructured":"Hoebers\u00a0F, Rios\u00a0E, Troost\u00a0E, van den Ende\u00a0P, Kross\u00a0K, Lacko\u00a0M, Lalisang\u00a0R, Kremer\u00a0B, de Jong\u00a0J (2013) Definitive radiation therapy for treatment of laryngeal carcinoma. Strahlenther Onkol 189:834\u2013841","journal-title":"Strahlenther Onkol"},{"key":"1706_CR10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.anl.2016.08.002","volume":"44","author":"C Scherl","year":"2017","unstructured":"Scherl\u00a0C, Mantsopoulos\u00a0K, Semrau\u00a0S, Fietkau\u00a0R, Kapsreiter\u00a0M, Koch\u00a0M, Traxdorf\u00a0M, Grundtner\u00a0P, Iro\u00a0H (2017) Management of advanced hypopharyngeal and laryngeal cancer with and without cartilage invasion. Auris Nasus Larynx 44:333\u2013339","journal-title":"Auris Nasus Larynx"},{"key":"1706_CR11","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jamaoto.2014.1671","volume":"140","author":"UC Megwalu","year":"2014","unstructured":"Megwalu\u00a0UC, Sikora\u00a0AG (2014) Survival outcomes in advanced laryngeal cancer. JAMA Otolaryngol Head Neck Surg 140:855\u2013860","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"1706_CR12","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1007\/s00405-013-2564-3","volume":"270","author":"P Zb\u00e4ren","year":"2013","unstructured":"Zb\u00e4ren\u00a0P, de Bree\u00a0R, Takes\u00a0RP, Rinaldo\u00a0A, Ferlito\u00a0A (2013) Which is the most reliable diagnostic modality for detecting locally residual or recurrent laryngeal squamous cell carcinoma after (chemo)radiotherapy? Eur Arch Otorhinolaryngol 270:2787\u20132791","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"1706_CR13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.radonc.2015.10.010","volume":"118","author":"R de Bree","year":"2016","unstructured":"de Bree\u00a0R, van der Putten\u00a0L, van Tinteren\u00a0H, Wedman\u00a0J, Oyen\u00a0WJG, Janssen\u00a0LM, van den Brekel\u00a0MWM, Comans\u00a0EFI, Pruim\u00a0J, Takes\u00a0RP et al (2016) Effectiveness of an 18F-FDG-PET based strategy to optimize the diagnostic trajectory of suspected recurrent laryngeal carcinoma after radiotherapy: The RELAPS multicenter randomized trial. Radiother Oncol 118:251\u2013256","journal-title":"Radiother Oncol"},{"key":"1706_CR14","volume-title":"Continue NCCN guidelines panel disclosures NCCN gratefully acknowledges the following subcommittee member for her contributions on the development of the principles of imaging (IMG-A) NCCN guidelines version 2.2020 head and neck cancers","author":"M Fenton","year":"2020","unstructured":"Fenton\u00a0M, Foote\u00a0RL, Galloway\u00a0T, Gillison\u00a0ML, Haddad\u00a0RI, Hicks\u00a0WL, Hitchcock\u00a0YJ, Jimeno\u00a0A, Leizman\u00a0D, Pinto\u00a0HA et al (2020) Continue NCCN guidelines panel disclosures NCCN gratefully acknowledges the following subcommittee member for her contributions on the development of the principles of imaging (IMG-A) NCCN guidelines version 2.2020 head and neck cancers"},{"key":"1706_CR15","volume-title":"S3-Leitlinie Diagnostik, Therapie und Nachsorge des Larynxkarzinoms","author":"Leitlinienprogramm Onkologie","year":"2019","unstructured":"Leitlinienprogramm Onkologie (2019) S3-Leitlinie Diagnostik, Therapie und Nachsorge des Larynxkarzinoms"},{"key":"1706_CR16","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/j.oraloncology.2009.07.008","volume":"45","author":"LB Been","year":"2009","unstructured":"Been\u00a0LB, Hoekstra\u00a0HJ, Suurmeijer\u00a0AJH, Jager\u00a0PL, van der Laan\u00a0BFAM, Elsinga\u00a0PH (2009) 18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer. Oral Oncol 45:e211\u2013e215","journal-title":"Oral Oncol"},{"key":"1706_CR17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1177\/0003489419834312","volume":"128","author":"Z Mayo","year":"2019","unstructured":"Mayo\u00a0Z, Seyedin\u00a0SN, Mallak\u00a0N, Mott\u00a0SL, Menda\u00a0Y, Graham\u00a0M, Anderson\u00a0C (2019) Clinical utility of pretreatment and 3\u2011month 18F-fluorodeoxyglucose positron emission tomography\/computed tomography standardized uptake value in predicting and assessing recurrence in T3\u2013T4 laryngeal carcinoma treated with definitive radiation. Ann Otol Rhinol Laryngol 128:595\u2013600","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"1706_CR18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/coa.13242","volume":"44","author":"J Wedman","year":"2019","unstructured":"Wedman\u00a0J, Pruim\u00a0J, van der Putten\u00a0L, Hoekstra\u00a0OS, de Bree\u00a0R, van Dijk\u00a0BAC, van der Laan\u00a0BFAM (2019) Is C\u201111 methionine PET an alternative to 18\u2011F FDG-PET for identifying recurrent laryngeal cancer after radiotherapy? Clin Otolaryngol 44:124\u2013130","journal-title":"Clin Otolaryngol"},{"key":"1706_CR19","volume-title":"Continue NCCN guidelines panel disclosures","author":"RL Foote","year":"2019","unstructured":"Foote\u00a0RL, Gillison\u00a0ML, Haddad\u00a0RI, Hicks\u00a0WL, Hitchcock\u00a0YJ, Jimeno\u00a0A, Leizman\u00a0D, Maghami\u00a0E, Pinto\u00a0HA, Ridge\u00a0JA et\u00a0al (2019) Continue NCCN guidelines panel disclosures"},{"key":"1706_CR20","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00066-019-01483-0","volume":"195","author":"L Cozzi","year":"2019","unstructured":"Cozzi\u00a0L, Franzese\u00a0C, Fogliata\u00a0A, Franceschini\u00a0D, Navarria\u00a0P, Tomatis\u00a0S, Scorsetti\u00a0M (2019) Predicting survival and local control after radiochemotherapy in locally advanced head and neck cancer by means of computed tomography based radiomics. Strahlenther Onkol 195:805\u2013818","journal-title":"Strahlenther Onkol"},{"key":"1706_CR21","first-page":"993","volume":"18","author":"DI Kutler","year":"2004","unstructured":"Kutler\u00a0DI, Patel\u00a0SG, Shah\u00a0JP (2004) The role of neck dissection following definitive chemoradiation. Oncology 18:993\u2013998 (discussion 999, 1003\u20134, 1007)","journal-title":"Oncology"},{"key":"1706_CR22","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3389\/fonc.2019.00625","volume":"9","author":"A Dietz","year":"2019","unstructured":"Dietz\u00a0A, Wiegand\u00a0S, Kuhnt\u00a0T, Wichmann\u00a0G (2019) Laryngeal preservation approaches: considerations for new selection criteria based on the deLOS-II trial. Front Oncol 9:625","journal-title":"Front Oncol"},{"key":"1706_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/175398","volume":"2014","author":"M Zabrodsky","year":"2014","unstructured":"Zabrodsky\u00a0M, Lukes\u00a0P, Lukesova\u00a0E, Boucek\u00a0J, Plzak\u00a0J (2014) The role of narrow band imaging in the detection of recurrent laryngeal and hypopharyngeal cancer after curative radiotherapy. Biomed Res Int 2014:1\u20139","journal-title":"Biomed Res Int"},{"key":"1706_CR24","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s00330-012-2596-x","volume":"23","author":"DW Tshering Vogel","year":"2013","unstructured":"Tshering Vogel\u00a0DW, Zbaeren\u00a0P, Geretschlaeger\u00a0A, Vermathen\u00a0P, De Keyzer\u00a0F, Thoeny\u00a0HC (2013) Diffusion-weighted MR imaging including bi-exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers. Eur Radiol 23:562\u2013569","journal-title":"Eur Radiol"},{"key":"1706_CR25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejrad.2018.12.004","volume":"111","author":"JP Driessen","year":"2019","unstructured":"Driessen\u00a0JP, Peltenburg\u00a0B, Philippens\u00a0MEP, Huijbregts\u00a0JE, Pameijer\u00a0FA, de Bree\u00a0R, Janssen\u00a0LM, Terhaard\u00a0CHJ (2019) Prospective comparative study of MRI including diffusion-weighted images versus FDG PET-CT for the detection of recurrent head and neck squamous cell carcinomas after (chemo)radiotherapy. Eur J Radiol 111:62\u201367","journal-title":"Eur J Radiol"},{"key":"1706_CR26","doi-asserted-by":"crossref","first-page":"33836","DOI":"10.18632\/oncotarget.12952","volume":"8","author":"W Guo","year":"2017","unstructured":"Guo\u00a0W, Luo\u00a0D, Chen\u00a0X, Lin\u00a0M, Li\u00a0L, Zhao\u00a0Y, Yang\u00a0L, Hu\u00a0L, Zhao\u00a0X, Zhou\u00a0C (2017) Dynamic contrast-enhanced magnetic resonance imaging for pretreatment prediction of early chemo-radiotherapy response in larynx and hypopharynx carcinoma. Oncotarget 8:33836\u201333843","journal-title":"Oncotarget"},{"key":"1706_CR27","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.oraloncology.2012.02.023","volume":"48","author":"JS Bae","year":"2012","unstructured":"Bae\u00a0JS, Roh\u00a0J\u2011L, Lee\u00a0S, Kim\u00a0S\u2011B, Kim\u00a0JS, Lee\u00a0JH, Choi\u00a0S\u2011H, Nam\u00a0SY, Kim\u00a0SY (2012) Laryngeal edema after radiotherapy in patients with squamous cell carcinomas of the larynx and hypopharynx. Oral Oncol 48:853\u2013858","journal-title":"Oral Oncol"},{"key":"1706_CR28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.anl.2015.02.014","volume":"42","author":"M Mori","year":"2015","unstructured":"Mori\u00a0M, Yabuki\u00a0K, Taguchi\u00a0T, Nishimura\u00a0G, Takahashi\u00a0M, Komatsu\u00a0M, Oridate\u00a0N (2015) Long-term results of survival analysis after a\u00a05-year follow-up: efficacy of fluoro-2-deoxy-D-glucose positron emission tomography to evaluate responses to concurrent chemoradiotherapy for head and neck squamous cell carcinoma. Auris Nasus Larynx 42:263","journal-title":"Auris Nasus Larynx"},{"issue":"1","key":"1706_CR29","doi-asserted-by":"crossref","first-page":"E1271","DOI":"10.1002\/hed.24204","volume":"38","author":"T Sagardoy","year":"2016","unstructured":"Sagardoy\u00a0T, Fernandez\u00a0P, Ghafouri\u00a0A, Digue\u00a0L, Haaser\u00a0T, de Clermont-Galleran\u00a0H, Castetbon\u00a0V, de Mon\u00e8s\u00a0E (2016) Accuracy of (18) FDG PET-CT for treatment evaluation 3\u00a0months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2\u2011year minimum follow-up. Head Neck 38(1):E1271\u20136","journal-title":"Head Neck"},{"key":"1706_CR30","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.anl.2011.04.013","volume":"38","author":"M Mori","year":"2011","unstructured":"Mori\u00a0M, Tsukuda\u00a0M, Horiuchi\u00a0C, Matsuda\u00a0H, Taguchi\u00a0T, Takahashi\u00a0M, Nishimura\u00a0G, Komatsu\u00a0M, Niho\u00a0T, Sakuma\u00a0N et al (2011) Efficacy of fluoro-2-deoxy-D-glucose positron emission tomography to evaluate responses to concurrent chemoradiotherapy for head and neck squamous cell carcinoma. Auris Nasus Larynx 38:724\u2013729","journal-title":"Auris Nasus Larynx"},{"key":"1706_CR31","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.7314\/APJCP.2013.14.8.4847","volume":"14","author":"EK Uzel","year":"2013","unstructured":"Uzel\u00a0EK, Ekmekcioglu\u00a0O, Elicin\u00a0O, Halac\u00a0M, Uzel\u00a0OE (2013) Is FDG-PET-CT a valuable tool in prediction of persistent disease in head and neck cancer. Asian Pac J Cancer Prev 14:4847\u20134851","journal-title":"Asian Pac J Cancer Prev"},{"key":"1706_CR32","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.clon.2017.07.010","volume":"29","author":"C Nelissen","year":"2017","unstructured":"Nelissen\u00a0C, Sherriff\u00a0J, Jones\u00a0T, Guest\u00a0P, Colley\u00a0S, Sanghera\u00a0P, Hartley\u00a0A (2017) The role of positron emission tomography\/computed tomography imaging in head and neck cancer after radical chemoradiotherapy: a\u00a0single institution experience. Clin Oncol 29:753\u2013759","journal-title":"Clin Oncol"},{"key":"1706_CR33","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.clon.2017.07.010","volume":"29","author":"C Nelissen","year":"2017","unstructured":"Nelissen\u00a0C, Sherriff\u00a0J, Jones\u00a0T, Guest\u00a0P, Colley\u00a0S, Sanghera\u00a0P, Hartley\u00a0A (2017) The role of positron emission tomography\/computed tomography imaging in head and neck cancer after radical chemoradiotherapy: a\u00a0single institution experience. Clin Oncol (R Coll Radiol) 29:753\u2013759","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1706_CR34","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MNM.0000000000000809","volume":"39","author":"G Tatar","year":"2018","unstructured":"Tatar\u00a0G, Cermik\u00a0TF, Karagoz\u00a0Y, Gundogan\u00a0C, Karacetin\u00a0D, Yildiz\u00a0E, Yigit\u00a0O (2018) The value of whole-body contrast-enhanced 18F-FDG PET\/CT imaging in the diagnosis and staging of patients with laryngeal carcinoma. Nucl Med Commun 39:334\u2013342","journal-title":"Nucl Med Commun"},{"key":"1706_CR35","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1749-4486.2008.01688.x","volume":"33","author":"MG Isles","year":"2008","unstructured":"Isles\u00a0MG, McConkey\u00a0C, Mehanna\u00a0HM (2008) A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol 33:210\u2013222","journal-title":"Clin Otolaryngol"},{"key":"1706_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21170","volume":"21","author":"H Mehanna","year":"2017","unstructured":"Mehanna\u00a0H, McConkey\u00a0CC, Rahman\u00a0JK, Wong\u00a0W\u2011L, Smith\u00a0AF, Nutting\u00a0C, Hartley\u00a0AG, Hall\u00a0P, Hulme\u00a0C, Patel\u00a0DK et al (2017) PET-NECK: a\u00a0multicentre randomised phase III non-inferiority trial comparing a\u00a0positron emission tomography\u2013computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2\/N3) nodal metastases in patients with squamous cell head and neck cancer. Health Technol Assess 21:1\u2013122","journal-title":"Health Technol Assess"},{"key":"1706_CR37","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00259-011-1893-y","volume":"38","author":"T Gupta","year":"2011","unstructured":"Gupta\u00a0T, Master\u00a0Z, Kannan\u00a0S, Agarwal\u00a0JP, Ghsoh-Laskar\u00a0S, Rangarajan\u00a0V, Murthy\u00a0V, Budrukkar\u00a0A (2011) Diagnostic performance of post-treatment FDG PET or FDG PET\/CT imaging in head and neck cancer: a\u00a0systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 38:2083\u20132095","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1706_CR38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejca.2017.07.054","volume":"85","author":"AF Smith","year":"2017","unstructured":"Smith\u00a0AF, Hall\u00a0PS, Hulme\u00a0CT, Dunn\u00a0JA, McConkey\u00a0CC, Rahman\u00a0JK, McCabe\u00a0C, Mehanna\u00a0H (2017) Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer. Eur J Cancer 85:6\u201314","journal-title":"Eur J Cancer"},{"key":"1706_CR39","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/hed.1135","volume":"23","author":"CH Terhaard","year":"2001","unstructured":"Terhaard\u00a0CH, Bongers\u00a0V, van Rijk\u00a0PP, Hordijk\u00a0GJ (2001) F\u201118-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal\/pharyngeal cancer. Head Neck 23:933\u2013941","journal-title":"Head Neck"},{"key":"1706_CR40","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/hed.20790","volume":"30","author":"J Brouwer","year":"2008","unstructured":"Brouwer\u00a0J, Hooft\u00a0L, Hoekstra\u00a0OS, Riphagen\u00a0II, Castelijns\u00a0JA, de Bree\u00a0R, Leemans\u00a0CR (2008) Systematic review: accuracy of imaging tests in the diagnosis of recurrent laryngeal carcinoma after radiotherapy. Head Neck 30:889\u2013897","journal-title":"Head Neck"},{"key":"1706_CR41","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1055\/a-0573-0908","volume":"39","author":"J K\u00fcnzel","year":"2018","unstructured":"K\u00fcnzel\u00a0J, Strieth\u00a0S, Wirth\u00a0G, Bozzato\u00a0A (2018) Ultrasound in the re-staging of cervical metastases after chemoradiotherapy for head and neck cancer. Ultraschall Med 39:659\u2013666","journal-title":"Ultraschall Med"},{"key":"1706_CR42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejrad.2015.10.015","volume":"85","author":"E De Fiori","year":"2016","unstructured":"De Fiori\u00a0E, Conte\u00a0G, Ansarin\u00a0M, De Benedetto\u00a0L, Bonello\u00a0L, Alterio\u00a0D, Maffini\u00a0F, Bellomi\u00a0M, Preda\u00a0L (2016) The role of ultrasound-guided transcutaneous tru-cut biopsy in diagnosing untreated and recurrent laryngo-hypopharyngeal masses. Eur J Radiol 85:158\u2013163","journal-title":"Eur J Radiol"},{"key":"1706_CR43","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3233\/CH-2012-1593","volume":"52","author":"CM Wendl","year":"2012","unstructured":"Wendl\u00a0CM, M\u00fcller\u00a0S, Meier\u00a0J, Fellner\u00a0C, Eiglsperger\u00a0J, Gosau\u00a0M, Prantl\u00a0L, Stroszczynski\u00a0C, Jung\u00a0EM (2012) High resolution contrast-enhanced ultrasound and 3\u2011tesla dynamic contrast-enhanced magnetic resonance imaging for the preoperative characterization of cervical lymph nodes: first results. Clin Hemorheol Microcirc 52:153\u2013166","journal-title":"Clin Hemorheol Microcirc"},{"key":"1706_CR44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3233\/CH-199224","volume":"73","author":"J Rennert","year":"2019","unstructured":"Rennert\u00a0J, Wiesinger\u00a0I, Beyer\u00a0LP, Schicho\u00a0A, Stroszczynski\u00a0C, Wiggermann\u00a0P, Jung\u00a0EM (2019) Color coded perfusion analysis and microcirculation imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following thermal ablative techniques of primary and secondary liver malignancies. Clin Hemorheol Microcirc 73:73\u201383","journal-title":"Clin Hemorheol Microcirc"},{"key":"1706_CR45","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/MOO.0000000000000242","volume":"24","author":"C Arens","year":"2016","unstructured":"Arens\u00a0C, Kraft\u00a0M (2016) Endoscopic ultrasound of the larynx. Curr Opin Otolaryngol Head Neck Surg 24:128\u2013134","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"1706_CR46","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa1514493","volume":"374","author":"H Mehanna","year":"2016","unstructured":"Mehanna\u00a0H, Wong\u00a0W\u2011L, McConkey\u00a0CC, Rahman\u00a0JK, Robinson\u00a0M, Hartley\u00a0AGJ, Nutting\u00a0C, Powell\u00a0N, Al-Booz\u00a0H, Robinson\u00a0M et al (2016) PET-CT surveillance versus neck dissection in advanced head and neck cancer. N\u00a0Engl J Med 374:1444\u20131454","journal-title":"N Engl J Med"},{"key":"1706_CR47","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00066-016-1002-z","volume":"192","author":"RM Hermann","year":"2016","unstructured":"Hermann\u00a0RM, Christiansen\u00a0H (2016) Restaging PET-CT after radiochemotherapy can spare patients with advanced head and neck cancer from neck dissection provided they are in complete remission. Strahlenther Onkol 192:589\u2013591","journal-title":"Strahlenther Onkol"},{"key":"1706_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/703450","author":"F De Felice","year":"2015","unstructured":"De Felice\u00a0F, Musio\u00a0D, Tombolini\u00a0V (2015) Follow-up in head and neck cancer: a management dilemma. Adv Otolaryngol. https:\/\/doi.org\/10.1155\/2015\/703450","journal-title":"Adv Otolaryngol"},{"key":"1706_CR49","volume-title":"Anatomy, head and neck, larynx","author":"J Su\u00e1rez-Quintanilla","year":"2020","unstructured":"Su\u00e1rez-Quintanilla\u00a0J, Fern\u00e1ndez Cabrera\u00a0A, Sharma\u00a0S (2020) Anatomy, head and neck, larynx. StatPearls Publishing, Treasure Island (FL)"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-020-01706-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-020-01706-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-020-01706-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T17:36:37Z","timestamp":1613756197000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-020-01706-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,20]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["1706"],"URL":"https:\/\/doi.org\/10.1007\/s00066-020-01706-9","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,20]]},"assertion":[{"value":"1 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.\u00a0Seebauer, B.\u00a0Hackenberg, J.\u00a0Grosse, J.\u00a0Rennert, E.-M.\u00a0Jung, I.\u00a0Ugele, I.\u00a0Michaelides, H.\u00a0Mehanna, M.G.\u00a0Hautmann, C.\u00a0Bohr, and J.\u00a0K\u00fcnzel declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}